TABLE 3.

Univariate and multivariate regression of CR signature and other clinical features in validation cohort.

Characteristic	Univariate analysis		Multivariate analysis
	Hazard ratio (95% CI)	p-value	Hazard ratio (95% CI)	p-value
Gender	1.358 (0.467–3.954)	0.574	—	—
Stage	1.700 (1.036–2.790)	0.036	2.589 (1.353–4.954)	0.004
Risk score	12,191.428 (18.539–8,017,342.094)	0.004	1676261.622 (370.856–7576636516.957)	<0.001